News & Perspective

Jan 11, 2013

Jan 11, 2013

US flu activity shifts west as some national markers drop

(CIDRAP News) – Flu activity indicators showed some wobble last week, which might suggest that activity in the United States is starting to ebb in some locations or could reflect some artifacts of disease reporting that health officials sometimes see over the holiday period.

Jan 25, 2013

Jan 25, 2013

CDC sees mixed flu picture, remaining threat for seniors

(CIDRAP News) – Deaths from pneumonia and flu in the United States rose sharply last week, with a rise in hospitalizations that continues to hit older people the hardest, though other disease indicators showed declines, the US Centers for Disease Control and Prevention (CDC) reported today.

Jan 30, 2013

Jan 30, 2013

Study finds post-H1N1-vaccination rise in narcolepsy in 3 nations

(CIDRAP News) – A large study of narcolepsy background rates in six European countries before and after 2009 H1N1 pandemic vaccine campaigns confirmed increases in Finland and Sweden—the two countries that first reported the problem—but also detected a rise in Denmark.

Feb 08, 2013

Feb 08, 2013

US flu ebbs but still causes considerable illness

(CIDRAP News) – US flu indicators continued their decline last week, though many states are still reporting brisk levels of flu activity, the Centers for Disease Control and Prevention (CDC) reported today.

Feb 14, 2013

Feb 14, 2013

Euro studies show flu vaccine working best against type B

(CIDRAP News) – New European studies reported today in Eurosurveillance suggest that this year's influenza vaccine is providing good protection against influenza B viruses but only moderate protection against type A—findings more or less consistent with earlier results in the United States.

Feb 15, 2013

Feb 15, 2013

CDC: Flu activity continues to slow

(CIDRAP News) – The nation's flu markers show that the flu has probably peaked, though many states are still reporting plenty of infections and hospitalizations, the US Centers for Disease Control and Prevention (CDC) said today.

Though the percentage of doctors' visits for influenza-like illness (ILI) is still above baselines in all regions of the country, the overall national level fell from 3.6% to 3.2% last week, according to the CDC.

Feb 22, 2013

Feb 22, 2013

Flu activity continues its slow retreat

(CIDRAP News) – Some of the key markers that US officials use to track flu continued to tumble last week, though activity was still elevated in most parts of the country, according to the Centers for Disease Control and Prevention (CDC) today.

Nationally, the percentage of doctors visits for flulike illness fell from 3.2% to 2.8% last week, with all parts of the country still above regional baselines.

Mar 01, 2013

Mar 01, 2013

US flu activity ebbs further as influenza B surges

(CIDRAP News) – Most US influenza activity indicators showed a continued decrease last week as influenza B for the first time this season became the predominant strain, according to new data presented today by the Centers for Disease Control and Prevention (CDC).

Of 7,609 respiratory specimens tested by reporting labs, 16.9% were positive for flu, about the same as the previous week, when 16.8% tested positive.

Mar 01, 2013

Study: Getting flu shot 2 years in a row may lower protection

(CIDRAP News) – Experts are puzzled by a new study in which influenza vaccination seemed to provide little or no protection against flu in the 2010-11 season—and in which the only participants who seemed to benefit from the vaccine were those who hadn't been vaccinated the season before.

Mar 08, 2013

Mar 08, 2013

US flu activity almost back to baseline

(CIDRAP News) – Influenza activity in the United States continued to tumble last week, with one key marker—clinic visits for flulike illness—nearly approaching the national baseline, the US Centers for Disease Control and Prevention (CDC) said today.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»